Kevon Hekmatdoost, MD
Neurology · Richmond, VANPI 1144581661
Payments from drug & device makers
Across 49 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$193
- Livanova USA, Inc.$180
- Amgen$89
- Insightec,inc$78
- UCB, Inc.$65
- EMD Serono, Inc.$53
- plus $425 from 15 others
What the payments were for
- Speaking & faculty fees$141%
- Food & beverage$1,06999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $193 |
| Livanova USA, Inc. | 4 | $180 |
| Amgen | 1 | $89 |
| Insightec,inc | 1 | $78 |
| UCB, Inc. | 3 | $65 |
| EMD Serono, Inc. | 3 | $53 |
| Greenwich Biosciences, Inc. | 3 | $52 |
| Biogen | 3 | $51 |
| Sanofi | 3 | $47 |
| Genentech USA, Inc. | 3 | $46 |
| Novartis | 2 | $36 |
| Lundbeck LLC | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $26 |
| GE HealthCare | 1 | $23 |
| AstraZeneca | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| CSL Behring | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| SK Life Science, Inc. | 1 | $15 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$1,083 in reported general payments places this provider in the 40th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 46 | $39,838 |
| Lamotrigine OdtLamotrigine | 24 | $10,412 |
| Dalfampridine ErDalfampridine | 12 | $7,200 |
| Levetiracetam | 108 | $3,011 |
| Memantine Hcl | 87 | $2,479 |
| Lacosamide | 19 | $2,375 |
| Oxcarbazepine | 24 | $1,339 |
| Propranolol Hcl ErPropranolol Hcl | 27 | $1,317 |
| Lamotrigine | 48 | $1,206 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 32 | $944 |
| Gabapentin | 83 | $710 |
| Primidone | 48 | $624 |
| RivastigmineRivastigmine Tartrate | 14 | $586 |
| Donepezil Hcl | 43 | $460 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 25 | $442 |
Paid to pharmacies, not to this prescriber.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Alan SchulmanRichmond$426K
- Daniel HardyRichmond$382K
- Leslie CloudRichmond$338K
- Warren FeltonRichmond$322K
- Claudia TestaRichmond$224K
- Myla GoldmanRichmond$195K
- Matthew BoyceRichmond$178K
- John WittmanRichmond$75K
- Michelle BetzVirginia Beach$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.